Neogen Q1 2025 Adj. EPS $0.07 Misses $0.09 Estimate, Sales $217.000M Beat $215.056M Estimate
Portfolio Pulse from Benzinga Newsdesk
Neogen's Q1 2025 earnings per share missed estimates, but sales slightly exceeded expectations. The company reported a 5.23% decrease in sales compared to the same period last year.
October 10, 2024 | 10:57 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Neogen's Q1 2025 earnings per share of $0.07 missed the consensus estimate of $0.09, while sales of $217M slightly beat expectations. However, sales decreased by 5.23% compared to the same period last year.
The miss on EPS is likely to have a negative impact on Neogen's stock price in the short term, as it indicates lower profitability than expected. Although sales slightly exceeded expectations, the year-over-year decline in sales by 5.23% could further contribute to negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100